Temat: "Bromocriptine" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
Autorzy:: Debnath S; Department of Genetics and Plant Breeding, Institute of Agriculture, Visva-Bharati University, Sriniketan, West Bengal, India.
Sharma D; Department of Biochemistry, ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra, Uttar Pradesh, India.
Chaudhari SY; Department of Pharmaceutical Chemistry, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune, India.
Sharma R; Department University Institute of Pharma Sciences, Chandigarh University, Chandigarh, India.
Shaikh AA; Department of Pharmaceutics, SCES's Indira College of Pharmacy 'Niramay', Tathwade, Pune, Maharashtra, India.
Buchade RS; Department of Pharmaceutics, SCES's Indira College of Pharmacy 'Niramay', Tathwade, Pune, Maharashtra, India.
Kesari KK; Department of Applied Physics, School of Science, Aalto University, Espoo, Finland.
Abdel-Fattah AM; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
Algahtani M; Department of Laboratory & Blood Bank, Security Forces Hospital, Meca, Saudi Arabia.
Mheidat M; Medicine Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Alsaidalani R; Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Paul T; Department of Genetics and Plant Breeding, Institute of Agriculture, Visva-Bharati University, Sriniketan, West Bengal, India.
Sayed AA; Zoology Department, Faculty of Science, Cairo University, Giza, Egypt.
Abdel-Daim MM; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.; Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Jan 19; Vol. 18 (1), pp. e0279616. Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/drug therapy
Alzheimer Disease*/metabolism
Bromocriptine*/pharmacology
Claviceps*
Intracranial Aneurysm*/prevention & control
Toll-Like Receptor 4*/metabolism
Humans ; Molecular Docking Simulation ; Triticum/microbiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The Comparative Pharmaco- and Histokinetics of the Therapeutic Dose of Estradiol Valerate and Bromocriptine in Common Quails.
Autorzy:: Nadeem M; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Nisa MU; Basic Health Unit, Khuda Bakhsh Mahar District Bahawalpur, Pakistan.
Bangash MH; Basic Health Unit 14/8R, Khanewal, Pakistan.
Abideen ZU; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Sattar R; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Sattar H; Department of Biotechnology, The University of Lahore, Pakistan.
Ullah MS; Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Ruby T; Department of Zoology, Bahauddin Zakariya University, Multan, Pakistan.
Khan AA; Department of Zoology, Bahauddin Zakariya University, Multan, Pakistan.
Ahmad A; University of Chinese Academy of Science (UCAS), Beijing, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2022 Oct 11; Vol. 2022, pp. 5482895. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).
Typ publikacji:: Journal Article; Retracted Publication
MeSH Terms:: Coturnix*/physiology
Bromocriptine*/pharmacology
Animals ; Female ; Male ; Estradiol ; Mesylates

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma.
Autorzy:: Igata M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yagi Y; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Hanatani S; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Sakaguchi M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ishii N; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshinaga K; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kawashima J; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Motoshima H; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.; Pokaż więcej
Źródło:: Journal of diabetes investigation [J Diabetes Investig] 2021 Apr; Vol. 12 (4), pp. 668-671. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:: Case Reports
MeSH Terms:: Blood Glucose/*drug effects
Bromocriptine/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Dopamine Agonists/*therapeutic use
Prolactinoma/*drug therapy
Bromocriptine/pharmacology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Dopamine Agonists/pharmacology ; Female ; Humans ; Middle Aged ; Prolactinoma/complications

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.
Autorzy:: Aguayo-Cerón KA; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Calzada-Mendoza CC; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.
Méndez-Bolaina E; Facultad de Ciencias Químicas, Universidad Veracruzana , Veracruz, México.
Romero-Nava R; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.; Departamento de Farmacología, Hospital Infantil de México Federico Gómez (HIMFG) , México City, México.
Ocharan-Hernández ME; Sección de Estudios de Posgrado e Investigación, Escuela Superior De Medicina, Instituto Politécnico Nacional-Escuela Superior de Medicina , México City, México.; Pokaż więcej
Źródło:: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2020 Oct 02; Vol. 42 (7), pp. 675-679. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:: Journal Article
MeSH Terms:: Bromocriptine/*pharmacology
Cardiomegaly/*metabolism
Dopamine Agonists/*pharmacology
Myocardium/*metabolism
Receptors, Dopamine D2/*metabolism
Receptors, Prolactin/*metabolism
Animals ; Bromocriptine/metabolism ; Bromocriptine/therapeutic use ; Cardiomegaly/prevention & control ; Male ; Rats ; Receptors, Dopamine D2/agonists

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype.
Autorzy:: Furman DJ; University of California, Berkeley.
White RL 3rd; University of California, Berkeley.; Washington University School of Medicine.
Naskolnakorn J; University of California, Berkeley.
Ye J; University of California, Berkeley.
Kayser A; University of California, San Francisco.
D'Esposito M; University of California, Berkeley.; Pokaż więcej
Źródło:: Journal of cognitive neuroscience [J Cogn Neurosci] 2020 May; Vol. 32 (5), pp. 804-821. Date of Electronic Publication: 2020 Jan 06.
Typ publikacji:: Journal Article
MeSH Terms:: Bromocriptine/*pharmacology
Catechol O-Methyltransferase/*genetics
Catechol O-Methyltransferase Inhibitors/*pharmacology
Cerebral Cortex/*metabolism
Corpus Striatum/*metabolism
Dopamine/*metabolism
Dopamine Agonists/*pharmacology
Executive Function/*drug effects
Psychomotor Performance/*drug effects
Tolcapone/*pharmacology
Adult ; Bromocriptine/administration & dosage ; Catechol O-Methyltransferase Inhibitors/administration & dosage ; Dopamine Agonists/administration & dosage ; Female ; Humans ; Male ; Tolcapone/administration & dosage ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A success targeted nano delivery to lung cancer cells with multi-walled carbon nanotubes conjugated to bromocriptine.
Autorzy:: Kamazani FM; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Sotoodehnejad Nematalahi F; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Siadat SD; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Pornour M; Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland, College Park, USA.
Sheikhpour M; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran. m_.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran. m_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Dec 24; Vol. 11 (1), pp. 24419. Date of Electronic Publication: 2021 Dec 24.
Typ publikacji:: Journal Article
MeSH Terms:: Bromocriptine/*administration & dosage
Cell Survival/*drug effects
Lung Neoplasms/*drug therapy
Nanoparticle Drug Delivery System/*pharmacology
Cell Line, Tumor ; Humans ; Nanotubes, Carbon

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
Autorzy:: Ezrokhi M; VeroScience LLC, Tiverton, RI 02878, USA.
Zhang Y; VeroScience LLC, Tiverton, RI 02878, USA.
Luo S; VeroScience LLC, Tiverton, RI 02878, USA.
Cincotta AH; VeroScience LLC, Tiverton, RI 02878, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Jun 07; Vol. 22 (11). Date of Electronic Publication: 2021 Jun 07.
Typ publikacji:: Journal Article
MeSH Terms:: Circadian Rhythm*
Bromocriptine/*pharmacology
Cardiovascular Diseases/*drug therapy
Diet, High-Fat/*adverse effects
Hormone Antagonists/*pharmacology
Hypertension/*complications
Metabolic Syndrome/*drug therapy
Animals ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/pathology ; Insulin Resistance ; Male ; Metabolic Syndrome/etiology ; Metabolic Syndrome/pathology ; Rats ; Rats, Inbred SHR ; Rats, Sprague-Dawley

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.
Autorzy:: Palle S; a DMPK & Clinical Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University , Warangal , India.
Neerati P; a DMPK & Clinical Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University , Warangal , India.; Pokaż więcej
Źródło:: Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2018 Oct; Vol. 48 (10), pp. 1028-1036. Date of Electronic Publication: 2017 Nov 10.
Typ publikacji:: Journal Article
MeSH Terms:: Bromocriptine/*pharmacokinetics
Cytochrome P-450 CYP3A/*metabolism
Cytochrome P-450 CYP3A Inhibitors/*pharmacokinetics
Cytochrome P-450 CYP3A Inhibitors/*pharmacology
Intestines/*enzymology
Liver/*enzymology
Nanoparticles/*chemistry
Quercetin/*pharmacology
Administration, Oral ; Animals ; Biological Transport/drug effects ; Bromocriptine/administration & dosage ; Bromocriptine/blood ; Bromocriptine/pharmacology ; Calibration ; Cytochrome P-450 CYP3A Inhibitors/administration & dosage ; Cytochrome P-450 CYP3A Inhibitors/blood ; Male ; Microsomes/drug effects ; Microsomes/enzymology ; Nanoparticles/ultrastructure ; Permeability ; Rats, Wistar

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Various and sundry recent publications.
Autorzy:: Bloomgarden Z; Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.; Pokaż więcej
Źródło:: Journal of diabetes [J Diabetes] 2021 Jan; Vol. 13 (1), pp. 4-6. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji:: Editorial
MeSH Terms:: Bromocriptine/*therapeutic use
Diabetes Mellitus, Type 1/*physiopathology
Diabetes Mellitus, Type 2/*physiopathology
Heart Rate/*physiology
Insulin Resistance/*physiology
Diabetes Mellitus, Type 1/mortality ; Heart Rate/drug effects ; Humans ; Obesity/physiopathology

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Idiopathic granulomatous mastitis associated with hyperprolactinemia: A nonoperative approach.
Autorzy:: Li J; School of Medicine, Griffith University, Gold Coast, QLD, Australia.
McGregor HP; Redcliffe Hospital, Redcliffe, QLD, Australia.; University of Queensland, Brisbane, QLD, Australia.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2017 Nov; Vol. 23 (6), pp. 742-744. Date of Electronic Publication: 2017 Aug 27.
Typ publikacji:: Case Reports
MeSH Terms:: Bromocriptine/*therapeutic use
Dopamine Agonists/*therapeutic use
Granulomatous Mastitis/*diagnosis
Hyperprolactinemia/*diagnosis
Bromocriptine/administration & dosage ; Diagnosis, Differential ; Dopamine Agonists/administration & dosage ; Female ; Granulomatous Mastitis/complications ; Granulomatous Mastitis/drug therapy ; Humans ; Hyperprolactinemia/complications ; Hyperprolactinemia/drug therapy ; Middle Aged

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Large painful lactating adenomas effectively treated during pregnancy with bromocriptine.
Autorzy:: Mendez MA; University of Missouri Kansas City School of Medicine, Kansas City, Missouri.
Jones KM; University of Missouri Kansas City School of Medicine, Kansas City, Missouri.
Reiman TR; University of Missouri Kansas City School of Medicine, Kansas City, Missouri.
Kremer HL; University of Missouri Kansas City School of Medicine, Kansas City, Missouri.; Truman Medical Centers, Kansas City, Missouri.
Ahmadiyeh N; University of Missouri Kansas City School of Medicine, Kansas City, Missouri.; Truman Medical Centers, Kansas City, Missouri.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2019 Sep; Vol. 25 (5), pp. 974-976. Date of Electronic Publication: 2019 Jun 04.
Typ publikacji:: Case Reports
MeSH Terms:: Adenoma/*drug therapy
Breast Neoplasms/*drug therapy
Bromocriptine/*therapeutic use
Hormone Antagonists/*therapeutic use
Pregnancy Complications, Neoplastic/*drug therapy
Adult ; Female ; Humans ; Pain/drug therapy ; Pregnancy ; Pregnancy Trimester, Third

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Differential expression of Sox9 protein and proteoglycans in the epiphyseal cartilage of bromocriptine-treated pregnant and lactating rats.
Autorzy:: Wongdee K; Faculty of Allied Health Sciences, Burapha University, Chonburi, 20131, Thailand.; Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
Lertsuwan K; Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.; Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
Thonapan N; Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.; Department of Physiology, Faculty of Science, Mahidol University, Rama VI Road, Bangkok, 10400, Thailand.
Teerapornpuntakit J; Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.; Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
Charoenphandhu N; Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, 10400, Thailand. .; Department of Physiology, Faculty of Science, Mahidol University, Rama VI Road, Bangkok, 10400, Thailand. .; Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, 73170, Thailand. .; The Academy of Science, The Royal Society of Thailand, Dusit, Bangkok, 10300, Thailand. .; Pokaż więcej
Źródło:: Anatomical science international [Anat Sci Int] 2020 Mar; Vol. 95 (2), pp. 277-285. Date of Electronic Publication: 2019 Dec 21.
Typ publikacji:: Journal Article
MeSH Terms:: Bromocriptine/*pharmacology
Gene Expression/*drug effects
Growth Plate/*metabolism
Lactation/*metabolism
Pregnancy, Animal/*metabolism
Proteoglycans/*metabolism
SOX9 Transcription Factor/*genetics
SOX9 Transcription Factor/*metabolism
Animals ; Female ; Lactation/genetics ; Pregnancy ; Pregnancy, Animal/genetics ; Rats ; Up-Regulation/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Autorzy:: Košec A; Department of Otorhinolaryngology and Head and Neck Surgery, Zagreb School of Medicine, University Hospital Centre 'Sestre Milosrdnice,' Croatia.
Kruljac I; Department of Endocrinology, Diabetes and Metabolic Diseases 'Mladen Sekso,' University Hospital Centre 'Sestre Milosrdnice,' Zagreb, Croatia.
Ajduk J; Department of Otorhinolaryngology and Head and Neck Surgery, Zagreb School of Medicine, University Hospital Centre 'Sestre Milosrdnice,' Croatia.; Pokaż więcej
Źródło:: American journal of audiology [Am J Audiol] 2019 Sep 13; Vol. 28 (3), pp. 548-552. Date of Electronic Publication: 2019 Aug 20.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Bromocriptine/*therapeutic use
Cochlear Diseases/*drug therapy
Hearing Loss, Sensorineural/*drug therapy
Hormone Antagonists/*therapeutic use
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Adult ; Audiometry, Pure-Tone ; Cochlear Diseases/complications ; Diuretics/therapeutic use ; Furosemide/therapeutic use ; Glucocorticoids/therapeutic use ; Hearing Loss, Sensorineural/complications ; Humans ; Magnetic Resonance Imaging ; Male ; Methylprednisolone/therapeutic use ; Pituitary Neoplasms/complications ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/pathology ; Prolactinoma/complications ; Prolactinoma/diagnostic imaging ; Prolactinoma/pathology ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Repositioning of bromocriptine for treatment of acute myeloid leukemia.
Autorzy:: Lara-Castillo MC; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.
Cornet-Masana JM; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.
Etxabe A; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.
Banús-Mulet A; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.
Torrente MÁ; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Nomdedeu M; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Díaz-Beyá M; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.
Esteve J; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain.; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.
Risueño RM; Centre Esther Koplowitz, Josep Carreras Leukaemia Research Institute, Campus Clínic-University of Barcelona, Rosselló 149-153, 08036, Barcelona, Spain. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2016 Sep 07; Vol. 14, pp. 261. Date of Electronic Publication: 2016 Sep 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Repositioning*
Bromocriptine/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Adult ; Bromocriptine/pharmacology ; CD11b Antigen/metabolism ; Cell Line, Tumor ; Cell Survival/drug effects ; Female ; Humans ; Leukemia, Myeloid, Acute/pathology ; Male ; Middle Aged ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Serum prolactin level in chronic urticaria: Is bromocriptine inducing remission in chronic urticaria?
Autorzy:: Soliman M; a Dermatology, Venereology and Andrology Department, Faculty of Medicine , Zagazig University , Sharkia , Egypt.
Khattab FM; a Dermatology, Venereology and Andrology Department, Faculty of Medicine , Zagazig University , Sharkia , Egypt.
Ebrahim HM; a Dermatology, Venereology and Andrology Department, Faculty of Medicine , Zagazig University , Sharkia , Egypt.
Nasr M; a Dermatology, Venereology and Andrology Department, Faculty of Medicine , Zagazig University , Sharkia , Egypt.; Pokaż więcej
Źródło:: The Journal of dermatological treatment [J Dermatolog Treat] 2018 Dec; Vol. 29 (8), pp. 826-830. Date of Electronic Publication: 2018 May 10.
Typ publikacji:: Journal Article
MeSH Terms:: Bromocriptine/*therapeutic use
Hormone Antagonists/*therapeutic use
Prolactin/*blood
Urticaria/*blood
Adult ; Biomarkers/blood ; Chronic Disease ; Female ; Humans ; Male ; Middle Aged ; Quality of Life ; Urticaria/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism.
Autorzy:: Sahney A; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Sharma BC; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Jindal A; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Anand L; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Arora V; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Vijayaraghavan R; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Dhamija RM; Department of Neurology, Institute of Liver and Biliary Sciences, New Delhi, India.
Kumar G; Department of Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, India.
Bhardwaj A; Department of Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, India.
Sarin SK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2019 Apr; Vol. 39 (4), pp. 684-693. Date of Electronic Publication: 2019 Feb 04.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Antiparkinson Agents/*therapeutic use
Bromocriptine/*therapeutic use
Liver Cirrhosis/*complications
Parkinsonian Disorders/*drug therapy
Adult ; Double-Blind Method ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Parkinsonian Disorders/etiology ; Proportional Hazards Models ; Severity of Illness Index ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs.
Autorzy:: Seeman MV; a Department of Psychiatry , University of Toronto , Toronto , ON , Canada.; Pokaż więcej
Źródło:: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2015 Oct; Vol. 31 (10), pp. 751-4. Date of Electronic Publication: 2015 Aug 18.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Bromocriptine/*adverse effects
Clomiphene/*adverse effects
Domperidone/*adverse effects
Dopamine Antagonists/*adverse effects
Estrogen Antagonists/*adverse effects
Leuprolide/*adverse effects
Psychoses, Substance-Induced/*diagnosis
Adult ; Bromocriptine/therapeutic use ; Clomiphene/therapeutic use ; Domperidone/therapeutic use ; Dopamine Antagonists/therapeutic use ; Estrogen Antagonists/therapeutic use ; Female ; Humans ; Leuprolide/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Autorzy:: Krysiak R; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
Gilowski W; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.; Cardiology Department, Chrzanow District Hospital, Chrzanow, Poland.
Szkrobka W; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
Okopien B; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.; Pokaż więcej
Źródło:: Cardiovascular therapeutics [Cardiovasc Ther] 2015 Oct; Vol. 33 (5), pp. 282-7.
Typ publikacji:: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atorvastatin/*therapeutic use
Bromocriptine/*therapeutic use
Dopamine Agonists/*therapeutic use
Hypercholesterolemia/*drug therapy
Hyperprolactinemia/*drug therapy
Hypolipidemic Agents/*therapeutic use
Adult ; Atorvastatin/administration & dosage ; Atorvastatin/pharmacology ; Bromocriptine/administration & dosage ; Bromocriptine/pharmacology ; C-Reactive Protein/analysis ; Cardiovascular Diseases/prevention & control ; Cholesterol, LDL/blood ; Diabetes Mellitus, Type 2/prevention & control ; Diet ; Dopamine Agonists/administration & dosage ; Dopamine Agonists/pharmacology ; Exercise ; Female ; Fibrinogen/analysis ; Homocysteine/blood ; Humans ; Hypercholesterolemia/epidemiology ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Hypolipidemic Agents/pharmacology ; Metformin/pharmacology ; Metformin/therapeutic use ; Middle Aged ; Premenopause ; Risk Factors ; Uric Acid/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients.
Autorzy:: Nagata E; Department of Neurology, Tokai University School of Medicine, Isehara, Japan.
Ogino M; Department of Neurology, Kitasato University School of Medicine, Sagamihara, Japan.
Iwamoto K; Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan.
Kitagawa Y; Department of Neurology, Tokai University Hachioji Hospital, Tokyo, Japan.
Iwasaki Y; Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan.
Yoshii F; Department of Neurology, Tokai University Oiso Hospital, Kanagawa, Japan.
Ikeda JE; Molecular Neurology, Faculty of Medicine, Kitasato University School of Medicine, Sagamihara, Japan.; Department of Pediatrics, Faculty of Medicine, University of Ottawa, ARC/Children's Hospital of Eastern Ontario, Ottawa, Canada.; Pokaż więcej
Corporate Authors:: ALS Consortium Investigators
Źródło:: PloS one [PLoS One] 2016 Feb 24; Vol. 11 (2), pp. e0149509. Date of Electronic Publication: 2016 Feb 24 (Print Publication: 2016).
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyotrophic Lateral Sclerosis/*drug therapy
Bromocriptine/*therapeutic use
Aged ; Bromocriptine/adverse effects ; Double-Blind Method ; Female ; Humans ; Leukocyte Count ; Male ; Middle Aged ; Riluzole/therapeutic use ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Inhibiting the onset of lactation. Is cabergoline an alternative to bromocriptine?
Źródło:: Prescrire international [Prescrire Int] 2015 Nov; Vol. 24 (165), pp. 276-7.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Bromocriptine/*therapeutic use
Ergolines/*therapeutic use
Lactation/*drug effects
Bromocriptine/adverse effects ; Cabergoline ; Dopamine Agonists/adverse effects ; Dopamine Agonists/therapeutic use ; Ergolines/adverse effects ; Europe ; Female ; France ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Bromocriptine"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji